The Promise of mRNA Vaccines: A Biotech and Industrial Perspective


Authors: N.A.C Jackson, K.E. Kester, D. Casimiro, S. Gurunathan and F. DeRosa

Journal: npj Vaccines

DOI: 10.1038/s41541-020-0159-8

Publication - Abstract

February 04, 2020

Vaccines Nucleic Acid Lipid Nanoparticles mRNA

Abstract

mRNA technologies have the potential to transform areas of medicine, including the prophylaxis of infectious diseases. The advantages for vaccines range from the acceleration of immunogen discovery to rapid response and multiple disease target manufacturing. A greater understanding of quality attributes that dictate translation efficiency, as well as a comprehensive appreciation of the importance of mRNA delivery, are influencing a new era of investment in development activities. The application of translational sciences and growing early-phase clinical experience continue to inform candidate vaccine selection. Here we review the state of the art for the prevention of infectious diseases by using mRNA and pertinent topics to the biotechnology and pharmaceutical industries.

limit search to this category
Advanced Search

Advanced Search

close
  • Publications
  • Application Notes
  • Posters
  • Workshops
  • Videos & Webinars
  • Articles
Search

Browse by Category

  • Application
    • Diagnostic and Imaging
    • Genetic Medicine
    • Hematology
    • Metabolic Disorders
    • Neuroscience
    • Oncology
    • Skeletal Disorders
    • Targeted Drug Delivery
    • Vaccines
    • Other Applications
    • Cell therapy
  • Formulation
    • Liposomes
    • Nucleic Acid Lipid Nanoparticles
    • Polymeric Nanoparticles
    • Other Formulations
  • Payload
    • DNA
    • microRNA
    • mRNA
    • siRNA
    • Small Molecule Drugs
    • Other Payloads


related content

Publication - Abstract

Nov 16, 2014
Advances in Genetics

Lipid Nanoparticles for Short Interfering RNA Delivery

A.K.K. Leung, Y.Y.C. Tam and P.R. Cullis

Genetic Medicine Liposomes Nucleic Acid Lipid Nanoparticles

The discovery of RNA interference (RNAi) in mammalian cells has created a new class of therapeutics based on the reversible silencing of specific disease-causing genes.

Read More


Publication - Abstract

Mar 13, 2021
Molecular Therapy Nucleic Acids

Functionalized Lipid Nanoparticles for Subcutaneous Administration of mRNA to Achieve Systemic Exposures of a Therapeutic Protein

N. Davies, D. Hovdal, N. Edmunds, P. Nordberg, S. Andersson, et. al.

mRNA Nucleic Acid Lipid Nanoparticles Other Applications
Lipid nanoparticles (LNPs) are the most clinically advanced delivery system for RNA-based drugs but have predominantly been investigated for intravenous and intramuscular administration. Subcutaneous administration opens the possibility of patient self-administration and hence lo...
Read More


Sign Up and Stay Informed
Sign up today to automatically receive new Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.
Sign Up